Skip to main content

Abstract

Genital herpes is one of the most common sexually transmitted diseases globally, and is associated with significant physical and psychological morbidity. However, upwards of 90% of infected individuals are unaware they are infected. Genital herpes is caused by herpes simplex virus type 1 (HSV-1) or herpes simplex type 2 (HSV-2). While there are differences between HSV-1 and HSV-2, both strains can cause ocular, oral, cutaneous and genital infections. HSV must come in contact with mucosal surfaces or abraded skin to initiate infection. Once infected, HSV persists indefinitely in a dormant state within sensory nerve ganglia until it is reactivated and causes a recurrent infection (Herpes simplex virus infections. 2. 2nd ed. Detroit: Charles Scribners & Sons; 2010. p. 823–828; Groves Am Fam Physician 93(11):928, 2016; Solomon et al. N Engl J Med 375(7):666, 2016; Bernstein et al. Clin Infect Dis 56(3):344–51, 2013) The herpes virus typically causes painful ulcerations at the site of infection, but these lesions do not have to be present to transmit the infection (asymptomatic shedding). On the basis of clinical examination, it is often impossible to determine definitively whether a first symptomatic episode of genital herpes is initial or recurrent disease. There are several different modalities to test for HSV infection, but PCR has emerged as the most reliable and sensitive method to confirm infection. A primary episode of HSV should be treated with oral antiviral therapy to prevent prolonged clinical illness with severe genital ulcerations. Prevention of genital HSV should primarily focus on decreasing overall HSV transmission and decreasing the morbidity and psychological stress for those already infected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Herpes simplex virus infections, vol. 2, 2010. 2nd ed. Detroit: Charles Scribners & Sons. p. 823–8.

    Google Scholar 

  2. Groves MJ. Genital herpes: a review. Am Fam Physician. 2016;93(11):928. http://www.ncbi.nlm.nih.gov/pubmed/27281837

    PubMed  Google Scholar 

  3. Solomon CG, Gnann JW Jr, Whitley RJ. Genital herpes. N Engl J Med. 2016;375(7):666. http://search.proquest.com/docview/1813629926

    Article  Google Scholar 

  4. Bernstein DI, Bellamy AR, Hook EW 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–51. http://www.ncbi.nlm.nih.gov/pubmed/23087395. https://doi.org/10.1093/cid/cis891.

    Article  CAS  PubMed  Google Scholar 

  5. Fatahzadeh M. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007;57(5):737–63. http://www.sciencedirect.com/science/article/pii/S0190962207010456. https://doi.org/10.1016/j.jaad.2007.06.027.

    Article  PubMed  Google Scholar 

  6. Gutierrez KM. Rethinking herpes simplex virus infections in children and adolescents. J Pediatr. 2007;151(4):336–8. http://www.sciencedirect.com/science/article/pii/S0022347607005562. https://doi.org/10.1016/j.jpeds.2007.05.052.

    Article  PubMed  Google Scholar 

  7. Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370(9605):2127–37. http://www.sciencedirect.com/science/article/pii/S0140673607619084. https://doi.org/10.1016/S0140-6736(07)61908-4.

    Article  PubMed  Google Scholar 

  8. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010. J Infect Dis. 2014;209(3):325–33. http://www.ncbi.nlm.nih.gov/pubmed/24136792. https://doi.org/10.1093/infdis/jit458.

    Article  PubMed  Google Scholar 

  9. Xu F. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr. 2007;151(4):374–7. http://www.sciencedirect.com/science/article/pii/S0022347607004428. https://doi.org/10.1016/j.jpeds.2007.04.065.

    Article  PubMed  Google Scholar 

  10. Rana RK, Pimenta JM, Rosenberg DM, et al. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm Infect. 2006;82(1):69–74. http://www.ncbi.nlm.nih.gov/pubmed/16461610. https://doi.org/10.1136/sti.2004.012989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. U.S. Preventive Services Task Force. Behavioral counseling to prevent sexually transmitted infections: U.S. preventive services task force recommendation statement. Ann Intern Med. 2008;149(7):W95. http://www.annals.org/content/149/7/491.abstract

    Article  Google Scholar 

  12. Auslander BA, Catallozzi M, Davis G, Succop PA, Stanberry LR, Rosenthal SL. Adolescents’ and young women’s use of a microbicide surrogate product when receiving oral sex. J Pediatr Adolesc Gynecol. 2014;27(1):37–40. http://www.ncbi.nlm.nih.gov/pubmed/24315715. https://doi.org/10.1016/j.jpag.2013.08.013.

    Article  PubMed  Google Scholar 

  13. Fanfair R, Zaidi A, Taylor L, Xu F, Gottlieb S, Markowitz L. Trends in seroprevalence of herpes simplex virus type 2 among non-hispanic blacks and non-hispanic whites aged 14 to 49 years—United States, 1988 to 2010. Sex Transm Dis. 2013;40(11):860–4. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00007435-201311000-00008. https://doi.org/10.1097/OLQ.0000000000000043.

    Article  PubMed  Google Scholar 

  14. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73. https://doi.org/10.1001/jama.296.8.964.

    Article  CAS  PubMed  Google Scholar 

  15. Gnann JW, Whitley RJ. Genital herpes. N Engl J Med. 2016;375(7):666–74.

    Article  Google Scholar 

  16. Kimberlin DW, Rouse DJ. Genital herpes. N Engl J Med. 2004;350(19):1970–7.

    Article  CAS  Google Scholar 

  17. Ward PL, Roizman B. Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet. 1994;10:267–74.

    Article  CAS  Google Scholar 

  18. Garland SM, Steben M. Genital herpes. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1098–110. http://www.ncbi.nlm.nih.gov/pubmed/25153069. https://doi.org/10.1016/j.bpobgyn.2014.07.015.

    Article  PubMed  Google Scholar 

  19. Kukhanova M, Korovina A, Kochetkov S. Human herpes simplex virus: life cycle and development of inhibitors. Biochem Moscow. 2014;79(13):1635–52. http://www.ncbi.nlm.nih.gov/pubmed/25749169. https://doi.org/10.1134/S0006297914130124.

    Article  CAS  Google Scholar 

  20. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342(12):844–50. http://content.nejm.org/cgi/content/abstract/342/12/844. https://doi.org/10.1056/NEJM200003233421203.

    Article  CAS  PubMed  Google Scholar 

  21. Fife KH, Williams JA, Thomas AL, Ofner S, Katz BP, Fortenberry JD. Herpes simplex virus type 2 infection in young adult women: risk factors for infection and frequency of viral shedding. Sex Transm Dis. 2010;37(4):248. http://www.ncbi.nlm.nih.gov/pubmed/20216477. https://doi.org/10.1097/OLQ.0b013e3181d4f866.

    Article  PubMed  Google Scholar 

  22. Merin A, Pachankis JE. The psychological impact of genital herpes stigma. J Health Psychol. 2011;16(1):80–90. http://journals.sagepub.com/doi/full/10.1177/1359105310367528. https://doi.org/10.1177/1359105310367528.

    Article  PubMed  Google Scholar 

  23. Sauerbrei A. Optimal management of genital herpes: current perspectives. Infect Drug Resist. 2016;9:129–41. http://www.ncbi.nlm.nih.gov/pubmed/27358569. https://doi.org/10.2147/IDR.S96164.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dhankani V, Kutz JN, Schiffer JT. Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons. PLoS Comput Biol. 2014;10(11):e1003922. http://www.ncbi.nlm.nih.gov/pubmed/25375183. https://doi.org/10.1371/journal.pcbi.1003922.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis. 2004;190(8):1374–81. http://www.jstor.org/stable/30078058. https://doi.org/10.1086/424519.

    Article  CAS  PubMed  Google Scholar 

  26. Tronstein E, Johnston C, Huang M, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305(14):1441–9. https://doi.org/10.1001/jama.2011.420. https://doi.org/10.1001/jama.2011.420.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99(5):1092–7. http://www.ncbi.nlm.nih.gov/pubmed/9062368. https://doi.org/10.1172/JCI119237.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sexually transmitted diseases: summary of 2015 CDC treatment guidelines. J Miss State Med Assoc. 2015;56(12):372. http://www.ncbi.nlm.nih.gov/pubmed/26975162

  29. Singh A, Preiksaitis J, Romanowski B. The laboratory diagnosis of herpes simplex virus infections. Can J Infect Dis Med Microbiol. 2005;16(2):92–8. https://doi.org/10.1155/2005/318294.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ramaswamy M, Mcdonald C, Smith M, et al. Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect. 2004;80(5):406–10. http://www.ncbi.nlm.nih.gov/pubmed/15459412. https://doi.org/10.1136/sti.2003.008201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Moseley RC, Corey L, Benjamin D, Winter C, Remington ML. Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol. 1981;13(5):913–8. http://jcm.asm.org/content/13/5/913.abstract

    Article  CAS  Google Scholar 

  32. Ratnam S, Severini A, Zahariadis G, Petric M, Romanowski B. The diagnosis of genital herpes – beyond culture: an evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. Can J Infect Dis Med Microbiol. 2007;18(4):233–40. https://doi.org/10.1155/2007/505364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Strick LB, Wald A. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol Diag Ther. 2006;10(1):17–28. http://www.ingentaconnect.com/content/adis/mdt/2006/00000010/00000001/art00002. https://doi.org/10.1007/BF03256439.

    Article  CAS  Google Scholar 

  34. Shevlin E, Morrow RA. Comparative performance of the uni-gold(TM) HSV-2 rapid: a point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory. J Clin Virol. 2014;61(3):378–81. http://www.ncbi.nlm.nih.gov/pubmed/25200648. https://doi.org/10.1016/j.jcv.2014.08.012.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Warren T, Gilbert L, Mark H. Availability of serologic and virologic testing for herpes simplex virus in the largest sexually transmitted disease clinics in the United States. Sex Transm Dis. 2011;38(4):267. http://www.ncbi.nlm.nih.gov/pubmed/21139516. https://doi.org/10.1097/OLQ.0b013e318202780a.

    Article  PubMed  Google Scholar 

  36. Krantz I, Löwhagen G-B, Ahlberg BM, Nilstun T. Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ Br Med J. 2004;329(7466):618–21. http://www.jstor.org/stable/25469080. https://doi.org/10.1136/bmj.329.7466.618.

    Article  Google Scholar 

  37. Whittington WL, Celum CL, Cent A, Ashley RL. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics. Sex Transm Dis. 2001;28(2):99–104. http://www.ncbi.nlm.nih.gov/pubmed/11234793. https://doi.org/10.1097/00007435-200102000-00007.

    Article  CAS  PubMed  Google Scholar 

  38. Wald A. Knowledge is power: a case for wider herpes simplex virus serologic testing. JAMA Pediatr. 2013;167(8):689–90. https://doi.org/10.1001/jamapediatrics.2013.459.

    Article  Google Scholar 

  39. Roth AM, Van Der Pol B, Fortenberry JD, et al. Herpes simplex virus type 2 serological testing at a community court: predictors of test acceptance and seropositivity among female defendants. Int J STD AIDS. 2013;24(3):169–74. http://journals.sagepub.com/doi/full/10.1177/0956462412472442. https://doi.org/10.1177/0956462412472442.

    Article  CAS  PubMed  Google Scholar 

  40. Patwardhan V, Bhalla P. Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: a comparative study in indian population from a tertiary care hospital. Indian J Pathol Microbiol. 2016;59(3):318–21. http://www.ncbi.nlm.nih.gov/pubmed/27510668. https://doi.org/10.4103/0377-4929.188104.

    Article  PubMed  Google Scholar 

  41. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008;168(11):1137–44. https://doi.org/10.1001/archinte.168.11.1137

    Article  CAS  Google Scholar 

  42. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1):11–20. http://content.nejm.org/cgi/content/abstract/350/1/11. https://doi.org/10.1056/NEJMoa035144.

    Article  CAS  PubMed  Google Scholar 

  43. DeJesus E, Wald A, Warren T, et al. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects. J Infect Dis. 2003;188(7):1009–16. http://www.ncbi.nlm.nih.gov/pubmed/14513421. https://doi.org/10.1086/378416.

    Article  CAS  PubMed  Google Scholar 

  44. Warren T, Harris J, Brennan CA. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Clin Infect Dis. 2004;39(S5):S266. http://www.jstor.org/stable/4462962. https://doi.org/10.1086/422362.

    Article  Google Scholar 

  45. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir study group. J Infect Dis. 1994;169(6):1338. http://www.ncbi.nlm.nih.gov/pubmed/8195614

    Article  CAS  Google Scholar 

  46. Wald A, Langenberg AGM, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285(24):3100–6. https://doi.org/10.1001/jama.285.24.3100

    Article  CAS  Google Scholar 

  47. Caulfield P, Willis D. P57 to disclose or not to disclose. An exploration of the multi-disciplinary team’s role in advising patients about disclosure when diagnosed with genital herpes simplex virus (HSV). Sex Transm Infect. 2015;91(Suppl 1):A34. https://doi.org/10.1136/sextrans-2015-052126.100.

    Article  Google Scholar 

  48. Davis A, Roth A, Brand JE, Zimet GD, Van Der Pol B. Coping strategies and behavioural changes following a genital herpes diagnosis among an urban sample of underserved midwestern women. Int J STD AIDS. 2016;27(3):207–12. http://journals.sagepub.com/doi/full/10.1177/0956462415578955. https://doi.org/10.1177/0956462415578955.

    Article  PubMed  Google Scholar 

  49. Royer HR, Falk EC, Heidrich SM. Genital herpes beliefs: implications for sexual health. J Pediatr Adolesc Gynecol. 2013;26(2):109–16. http://www.ncbi.nlm.nih.gov/pubmed/23337309. https://doi.org/10.1016/j.jpag.2012.11.007.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Wald A, Krantz E, Selke S, Lairson E, Morrow RA, Zeh J. Knowledge of partners’ genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis. 2006;194(1):42–52. http://www.jstor.org/stable/30085806. https://doi.org/10.1086/504717.

    Article  PubMed  Google Scholar 

  51. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185(1):45–52. http://www.jstor.org/stable/30138124. https://doi.org/10.1086/338231.

    Article  PubMed  Google Scholar 

  52. Mujugira A, Magaret AS, Celum C, et al. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. J Infect Dis. 2013;208(9):1366–74. http://www.ncbi.nlm.nih.gov/pubmed/23901094. https://doi.org/10.1093/infdis/jit333.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Robinson NJ, Celum CL, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis. 2005;191(3):S107.

    PubMed  Google Scholar 

  54. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22(5):601.

    Article  CAS  Google Scholar 

  55. Mikuła T, Mian MM, Stańczak W, Cianciara J. The immune reconstitution inflammatory syndrome (IRIS) in HIV infected patient – case report. HIV AIDS Rev. 2007;6(3):25–31. http://www.sciencedirect.com/science/article/pii/S1730127010600768. https://doi.org/10.1016/S1730-1270(10)60076-8.

    Article  Google Scholar 

  56. Acyclovir Pregnancy Registry and Valacyclovir Pregnancy Registry Interim Report, December 1997. Glaxo Wellcome, RTP, NC 27709.

    Google Scholar 

  57. Centers for Disease Control and Prevention: Metropolitan Atlanta Congenital Defects Program, revised January 1998. https://www.cdc.gov/ncbddd/birthdefects/macdp.html.

  58. Cone RW, Hobson AC, Brown Z, et al. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA. 1994;272(10):792–6. https://doi.org/10.1001/jama.1994.03520100054033. https://doi.org/10.1001/jama.1994.03520100054033.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robyn R. Miller .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Duroseau, N.H., Miller, R.R. (2020). Herpes Simplex Virus. In: Hussen, S. (eds) Sexually Transmitted Infections in Adolescence and Young Adulthood. Springer, Cham. https://doi.org/10.1007/978-3-030-20491-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-20491-4_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-20490-7

  • Online ISBN: 978-3-030-20491-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics